Skip to main content
Top
Published in: BMC Nephrology 1/2018

Open Access 01-12-2018 | Research article

Increased risk of deep vein thrombosis in end-stage renal disease patients

Authors: Hsueh-Yi Lu, Kuang-Ming Liao

Published in: BMC Nephrology | Issue 1/2018

Login to get access

Abstract

Background

Previous studies have shown that chronic kidney disease increases the risk of deep vein thrombosis (DVT). DVT is the risk of pulmonary embolism among persons with end-stage renal disease (ESRD). Information on the incidence of DVT in ESRD is limited, and no studies have been conducted in the Asian population. The aim of our study was to investigate the incidence of DVT in Asian ESRD patients by comparing with the non-ESRD patients and to identify the associated risk factors.

Methods

This study retrieved patients who were diagnosed with ESRD (ICD-9-CM codes 585 or 586) between January 1, 2004, and December 31, 2010, from the National Health Insurance Research Database in Taiwan. All ESRD patients had received a catastrophic illness card from the Ministry of Health and Welfare in Taiwan, with the major illness identified as ESRD. Patients who had DVT before the index date or who had incomplete records were excluded from the analysis. A total of 4865 ESRD patients were enrolled. There are 3564 ESRD patients included after exclusion of patients with previous DVT and patients with incomplete records. The control subjects were randomly selected as the patients without ESRD by matching study subjects according to age (±3 years), gender, and the year of admission at a 2:1 ratio from the same dataset.

Results

The incidence rate of DVT was substantially higher in the ESRD group than in the without-ESRD group (20.9 vs. 1.46 per 10^4 person-years). The adjusted hazard ratio (aHR 13.92; 95% CI 9.25–20.95) of DVT for the ESRD patients was 13.92 times that for the non-ESRD patients. ESRD patients older than 50 years had a higher risk of DVT (aHR 1.65; 95% CI 1.13–2.40; P = 0.01). Hyperlipidemia was significantly associated with an increased risk of DVT (aHR 1.73; 95% CI 1.08–2.78; P = 0.02). ESRD patients with three or more comorbidities were substantially more likely to have DVT (aHR 1.45; 95% CI 1.03–2.03; P = 0.03).

Conclusions

ESRD patients had a higher risk of DVT than non-ESRD patients. Among the ESRD patients, being older than 50 years and having dyslipidemia increased the risk of DVT.
Literature
1.
go back to reference Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT study. Arch Intern Med. 1991;151:933–8.CrossRefPubMed Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT study. Arch Intern Med. 1991;151:933–8.CrossRefPubMed
2.
go back to reference Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998;158:585–93.CrossRefPubMed Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998;158:585–93.CrossRefPubMed
3.
go back to reference Hansson PO, Welin L, Tibblin G, Eriksson H. Deep vein thrombosis and pulmonary embolism in the general population. Arch Intern Med. 1997;157:1665–70.CrossRefPubMed Hansson PO, Welin L, Tibblin G, Eriksson H. Deep vein thrombosis and pulmonary embolism in the general population. Arch Intern Med. 1997;157:1665–70.CrossRefPubMed
4.
5.
go back to reference Abbott KC, Cruess DF, Agodoa LY, Sawyers ES, Tveit DP. Early renal insufficiency and late venous thromboembolism after renal transplantation in the United States. Am J Kidney Dis. 2004;43:120–30.CrossRefPubMed Abbott KC, Cruess DF, Agodoa LY, Sawyers ES, Tveit DP. Early renal insufficiency and late venous thromboembolism after renal transplantation in the United States. Am J Kidney Dis. 2004;43:120–30.CrossRefPubMed
6.
go back to reference Poli D, Zanazzi M, Antonucci E, Marcucci R, Rosati A, Bertoni E, Salvadori M, Liotta AA, Abbate R, Prisco D, Gensini GF. High rate of recurrence in renal transplant recipients after a first episode of venous thromboembolism. Transplantation. 2005;80:789–93.CrossRefPubMed Poli D, Zanazzi M, Antonucci E, Marcucci R, Rosati A, Bertoni E, Salvadori M, Liotta AA, Abbate R, Prisco D, Gensini GF. High rate of recurrence in renal transplant recipients after a first episode of venous thromboembolism. Transplantation. 2005;80:789–93.CrossRefPubMed
7.
go back to reference Wattanakit K, Cushman M, Stehman-Breen C, Heckbert SR, Folsom AR. Chronic kidney disease increases risk for venous thromboembolism. J Am Soc Nephrol. 2008;19(1):135–40.CrossRefPubMedPubMedCentral Wattanakit K, Cushman M, Stehman-Breen C, Heckbert SR, Folsom AR. Chronic kidney disease increases risk for venous thromboembolism. J Am Soc Nephrol. 2008;19(1):135–40.CrossRefPubMedPubMedCentral
8.
go back to reference Keller C, Katz R, Cushman M, Fried LF, Shlipak M. Association of kidney function with inflammatory and procoagulant markers in a diverse cohort: a cross-sectional analysis from the multi-ethnic study of atherosclerosis (MESA). BMC Nephrol. 2008;9:9.CrossRefPubMedPubMedCentral Keller C, Katz R, Cushman M, Fried LF, Shlipak M. Association of kidney function with inflammatory and procoagulant markers in a diverse cohort: a cross-sectional analysis from the multi-ethnic study of atherosclerosis (MESA). BMC Nephrol. 2008;9:9.CrossRefPubMedPubMedCentral
9.
go back to reference Dobrowolski C, Clark EG, Sood MM. Venous thromboembolism in chronic kidney disease: epidemiology, the role of proteinuria, CKD severity and therapeutics. J Thromb Thrombolysis. 2017;43(2):241–7.CrossRefPubMed Dobrowolski C, Clark EG, Sood MM. Venous thromboembolism in chronic kidney disease: epidemiology, the role of proteinuria, CKD severity and therapeutics. J Thromb Thrombolysis. 2017;43(2):241–7.CrossRefPubMed
10.
go back to reference Königsbrügge O, Lötsch F, Zielinski C, Pabinger I, Ay C. Chronic kidney disease in patients with cancer and its association with occurrence of venous thromboembolism and mortality. Thromb Res. 2014;134(1):44–9.CrossRefPubMed Königsbrügge O, Lötsch F, Zielinski C, Pabinger I, Ay C. Chronic kidney disease in patients with cancer and its association with occurrence of venous thromboembolism and mortality. Thromb Res. 2014;134(1):44–9.CrossRefPubMed
11.
go back to reference Kooiman J, den Exter PL, Cannegieter SC, le Cessie S, del Toro J, Sahuquillo JC, Pedrajas JM, Huisman MV. Impact of chronic kidney disease on the risk of clinical outcomes in patients with cancer-associated venous thromboembolism during anticoagulant treatment. J Thromb Haemost. 2013;11(11):1968–76.CrossRefPubMed Kooiman J, den Exter PL, Cannegieter SC, le Cessie S, del Toro J, Sahuquillo JC, Pedrajas JM, Huisman MV. Impact of chronic kidney disease on the risk of clinical outcomes in patients with cancer-associated venous thromboembolism during anticoagulant treatment. J Thromb Haemost. 2013;11(11):1968–76.CrossRefPubMed
12.
go back to reference Chertow GM, Mahaffey KW. Venous thromboembolism: yet another cardiovascular complication of chronic kidney disease? Circulation. 2012;126(16):1937–8.CrossRefPubMed Chertow GM, Mahaffey KW. Venous thromboembolism: yet another cardiovascular complication of chronic kidney disease? Circulation. 2012;126(16):1937–8.CrossRefPubMed
13.
go back to reference Mahmoodi BK, Gansevoort RT, Næss IA, et al. Association of mild to moderate chronic kidney disease with venous thromboembolism: pooled analysis of five prospective general population cohorts. Circulation. 2012;126(16):1964–71.CrossRefPubMedPubMedCentral Mahmoodi BK, Gansevoort RT, Næss IA, et al. Association of mild to moderate chronic kidney disease with venous thromboembolism: pooled analysis of five prospective general population cohorts. Circulation. 2012;126(16):1964–71.CrossRefPubMedPubMedCentral
14.
go back to reference Folsom AR, Lutsey PL, Astor BC, Wattanakit K, Heckbert SR, Cushman M. Atherosclerosis risk in communities study. Chronic kidney disease and venous thromboembolism: a prospective study. Nephrol Dial Transplant. 2010;25(10):3296–301.CrossRefPubMedPubMedCentral Folsom AR, Lutsey PL, Astor BC, Wattanakit K, Heckbert SR, Cushman M. Atherosclerosis risk in communities study. Chronic kidney disease and venous thromboembolism: a prospective study. Nephrol Dial Transplant. 2010;25(10):3296–301.CrossRefPubMedPubMedCentral
15.
go back to reference Wiesholzer M, Kitzwögerer M, Harm F, et al. Prevalence of preterminal pulmonary thromboembolism among patients on maintenance hemodialysis treatment before and after introduction of recombinant erythropoietin. Am J Kidney Dis. 1999;33(4):702–8.CrossRefPubMed Wiesholzer M, Kitzwögerer M, Harm F, et al. Prevalence of preterminal pulmonary thromboembolism among patients on maintenance hemodialysis treatment before and after introduction of recombinant erythropoietin. Am J Kidney Dis. 1999;33(4):702–8.CrossRefPubMed
16.
go back to reference Casserly LF, Reddy SM, Dember LM. Venous thromboembolism in end-stage renal disease. Am J Kidney Dis. 2000;36(2):405–11.CrossRefPubMed Casserly LF, Reddy SM, Dember LM. Venous thromboembolism in end-stage renal disease. Am J Kidney Dis. 2000;36(2):405–11.CrossRefPubMed
17.
go back to reference Noordzij M, Leffondre K, van Stralen KJ, et al. When do we need competing risks methods for survival analysis in nephrology? Nephrol Dial Transplant. 2013;28:2670–7.CrossRefPubMed Noordzij M, Leffondre K, van Stralen KJ, et al. When do we need competing risks methods for survival analysis in nephrology? Nephrol Dial Transplant. 2013;28:2670–7.CrossRefPubMed
18.
go back to reference Maruyama H, Gejyo F, Hanano M, Arakawa M. Acquired type II protein C deficiency in a long-term hemodialysis patient. Nephron. 1994;66:348–50.CrossRefPubMed Maruyama H, Gejyo F, Hanano M, Arakawa M. Acquired type II protein C deficiency in a long-term hemodialysis patient. Nephron. 1994;66:348–50.CrossRefPubMed
19.
go back to reference Mallamaci F, Zoccali C, Tripepi G, et al. Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients. Kidney Int. 2002;61:609–14.CrossRefPubMed Mallamaci F, Zoccali C, Tripepi G, et al. Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients. Kidney Int. 2002;61:609–14.CrossRefPubMed
20.
go back to reference Wagner R, Mattes J, Traindl O. Deep venous thrombosis in haemodialysis patients—a pointer to the presence of malignancy? Nephrol Dial Transplant. 1996;11:879–80.CrossRefPubMed Wagner R, Mattes J, Traindl O. Deep venous thrombosis in haemodialysis patients—a pointer to the presence of malignancy? Nephrol Dial Transplant. 1996;11:879–80.CrossRefPubMed
21.
go back to reference Zoccali C, Bode-Boger S, Mallamaci F, Benedetto F, Tripepi G, Malatino L, Cataliotti A, Bellanuova I, Fermo I, Frolich J, Boger R. Plasma con- centration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet. 2001;358:2113–7.CrossRefPubMed Zoccali C, Bode-Boger S, Mallamaci F, Benedetto F, Tripepi G, Malatino L, Cataliotti A, Bellanuova I, Fermo I, Frolich J, Boger R. Plasma con- centration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet. 2001;358:2113–7.CrossRefPubMed
22.
23.
go back to reference Chen CY, Liao KM. The incidence of deep vein thrombosis in Asian patients with chronic obstructive pulmonary disease. Medicine (Baltimore). 2015;94(44):e1741.CrossRef Chen CY, Liao KM. The incidence of deep vein thrombosis in Asian patients with chronic obstructive pulmonary disease. Medicine (Baltimore). 2015;94(44):e1741.CrossRef
24.
go back to reference Tveit DP, Hypolite IO, Hshieh P, et al. Chronic dialysis patients have high risk for pulmonary embolism. Am J Kidney Dis. 2002;39:1011–7.CrossRefPubMed Tveit DP, Hypolite IO, Hshieh P, et al. Chronic dialysis patients have high risk for pulmonary embolism. Am J Kidney Dis. 2002;39:1011–7.CrossRefPubMed
25.
go back to reference Engbers MJ, van Hylckama VA, Rosendaal FR. Venous thrombosis in the elderly: incidence, risk factors and risk groups. J Thromb Haemost. 2010;8(10):2105–12.CrossRefPubMed Engbers MJ, van Hylckama VA, Rosendaal FR. Venous thrombosis in the elderly: incidence, risk factors and risk groups. J Thromb Haemost. 2010;8(10):2105–12.CrossRefPubMed
26.
go back to reference Kuo TH, Li HY, Lin SH. Acute kidney injury and risk of deep vein thrombosis and pulmonary embolism in Taiwan: a nationwide retrospective cohort study. Thromb Res. 2017;151:29–35.CrossRefPubMed Kuo TH, Li HY, Lin SH. Acute kidney injury and risk of deep vein thrombosis and pulmonary embolism in Taiwan: a nationwide retrospective cohort study. Thromb Res. 2017;151:29–35.CrossRefPubMed
27.
go back to reference Cheng CL, Lee CH, Chen PS, Li YH, Lin SJ, Yang YH. Validation of acute myocardial infarction cases in the national health insurance research database in Taiwan. J Epidemiol. 2014;24(6):500–7.CrossRefPubMedPubMedCentral Cheng CL, Lee CH, Chen PS, Li YH, Lin SJ, Yang YH. Validation of acute myocardial infarction cases in the national health insurance research database in Taiwan. J Epidemiol. 2014;24(6):500–7.CrossRefPubMedPubMedCentral
28.
go back to reference Cheng CL, Kao YH, Lin SJ, Lee CH, Lai ML. Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf. 2011;20(3):236–42.CrossRefPubMed Cheng CL, Kao YH, Lin SJ, Lee CH, Lai ML. Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf. 2011;20(3):236–42.CrossRefPubMed
29.
go back to reference Tagalakis V, Kahn SR. Determining the test characteristics of claims-based diagnostic codes for the diagnosis of venous thromboembolism in a medical service claims database. Pharmacoepidemiol Drug Saf. 2011;20(3):304–7.CrossRefPubMed Tagalakis V, Kahn SR. Determining the test characteristics of claims-based diagnostic codes for the diagnosis of venous thromboembolism in a medical service claims database. Pharmacoepidemiol Drug Saf. 2011;20(3):304–7.CrossRefPubMed
Metadata
Title
Increased risk of deep vein thrombosis in end-stage renal disease patients
Authors
Hsueh-Yi Lu
Kuang-Ming Liao
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2018
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-018-0989-z

Other articles of this Issue 1/2018

BMC Nephrology 1/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.